Basic Information
Basic information for SOX9-AS1-239-18aa-1
Peptide Name SOX9-AS1-239-18aa-1
Genome Position chr17:72083921-72083974[-]
Species Human
Peptide Sequence MVSVTSPKGAKEEIHNLP
Peptide Length 18
Unique No (SOX9-AS1-204-18aa-1,SOX9-AS1-205-18aa,SOX9-AS1-210-18aa,SOX9-AS1-212-18aa,SOX9-AS1-213-18aa-3,SOX9-AS1-216-18aa,SOX9-AS1-218-18aa,SOX9-AS1-220-18aa-2,SOX9-AS1-221-18aa,SOX9-AS1-222-18aa,SOX9-AS1-224-18aa,SOX9-AS1-225-18aa-2,SOX9-AS1-226-18aa,SOX9-AS1-228-18aa-1,SOX9-AS1-229-18aa-3,SOX9-AS1-230-18aa-1,SOX9-AS1-231-18aa-3,SOX9-AS1-232-18aa-1,SOX9-AS1-233-18aa,SOX9-AS1-234-18aa-1,SOX9-AS1-235-18aa,SOX9-AS1-236-18aa,SOX9-AS1-237-18aa-1,SOX9-AS1-238-18aa)
Grand Average of Hydropathicity -0.3889
Relative Molecular Mass 2243.53
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000234899;SOX9-AS1
Transcript ID/Name ENST00000671151;SOX9-AS1-239
Transcript Length 1258
Coding Ability 0.6407
DNA Sequence Corresponding to Peptide ATGGTATCCGTAACATCCCCCAAAGGAGCTAAAGAAGAAATCCACAATTTACCA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :